Capsule Endoscopy Delivery at sCale Through Enhanced AI anaLysis Study (CESCAIL)

University Hospitals Coventry and Warwickshire NHS Trust

Status: Enrolling

Conditions: Bowel Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT06008847

RA545021

Details and patient eligibility

About

The CESCAIL study tests the use of Artificial Intelligence (AI) on a video taken from a minimally-invasive imaging device, to improve efficiency and accuracy of the detection of polyps, which are little outgrowths within the lining of the bowel.

Full description

Participants will be continuing to follow their standard care pathway, and there are no additional requirements of the participants other than providing consent for their pseudonymised capsule video and data to be used to test the AI system.

The participant's final diagnosis will only be determined by the clinician's standard analysis pathway and not influenced by the AI enabled analysis pathway. All data is de-identified before a video is created and re-identified only once the standard final report is signed-off by the referring clinician. Therefore, the risk of patient harm due to exposed data is minimised.

Enrollment: 674 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged 18 or over
• Patients who have been selected by overseeing clinician meeting NHS England criteria to undergo colon capsule endoscopy as part of their standard of care

Exclusion criteria

• Patients unable to provide consent to take part in the study

Trial design

674 participants in 1 patient group

Lower Gastrointestinal Symptoms

Description:

Participant aged over 18 with referred lower gastrointestinal symptoms